| LINE ITEM (USD / %) | FY 2025
FILED 2026-03-31 | FY 2024
FILED 2025-03-31 | FY 2023
FILED 2024-03-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.19B | $963.0M | $1.01B |
| YoY Revenue Growth % | +23.9% | -5.0% | — |
| Gross Profit | $359.4M | $325.7M | — |
| Gross Margin % | 30.1% | 33.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$119.3M | $54.6M | $107.1M |
| Operating Margin % | -10.0% | 5.7% | 10.6% |
| Net Income (GAAP) | -$229.5M | -$5.1M | $46.6M |
| EBITDA (Normalized) | -$105.0M | $71.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$146.2M | $45.6M | $67.2M |
| Capital Expenditures (CapEx) | $17.9M | $21.4M | — |
| Free Cash Flow (FCF) | -$164.1M | $24.2M | $67.2M |
| FCF Margin % | -13.7% | 2.5% | 6.6% |
| Return on Invested Capital (ROIC %) | -10.6% | 5.2% | — |
| Cash & Short-Term Equivalents | $35.5M | $41.2M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $922.9M | $871.6M | — |